Acusera hsCRP Linearity Verifier

Home - QC - Page 3

Acusera hsCRP Linearity Verifier

Therapeutic Drug Quality Control

Dedicated hsCRP Linearity Verifier supplied in a liquid ready-to-use format specifically for use on Roche Cobas analysers. Designed to objectively verify calibration whilst remaining convenient and easy to use, there are five distinct levels provided that span the instrument’s complete reportable range.

Features & Benefits

  • Convenient, liquid ready-to-use format
  • 5 levels provided
  • 14 day stability when stored at 2ºC to 8ºC
  • Shelf life of up to 2 years from date of manufacture
DescriptionSizeAnalytesCat No 
Acusera hsCRP Linearity Verifier5 x 1mL1LV10335

Analytes

  • High Sensitivity C-Reactive Protein (hsCRP)

Acusera CRP Linearity Verifier

Therapeutic Drug Quality Control

This dedicated CRP Linearity Verifier is supplied a liquid ready to-use format, specifically for use on Roche Cobas analysers. This verifier is designed to objectively verify calibration whilst remaining convenient and easy to use. There are five distinct levels provided that span the instruments’ complete reportable range.

Features & Benefits

  • Convenient, liquid ready-to-use format
  • 5 levels provided
  • 14 day stability when stored at 2ºC to 8ºC
  • Shelf life of up to 2 years from date of manufacture
DescriptionSizeAnalytesCat No 
Acusera C-Reactive Protein (CRP) Linearity Verifier5 x 1mL1LV10334

Analytes

  • C-Reactive Protein (CRP)

Linearity Verifier Sets

Slide

Acusera Linearity Verifier Sets are designed to challenge a larger section of an instruments reportable range and test if a system’s calibration is still valid. Our linearity materials cover a wide range of testing including, CRP, RF, Lipids, Therapeutic Drugs, Esoterics and more. Designed with user convenience in mind, all our linearity sets are supplied in a liquid format and in varying levels. Our unique combination of analytes enables laboratories to reduce the number of individual products required while ultimately reducing costs and time.

Complimentary, cloud-based data reduction software is supplied with all linearity sets, providing a graphical representation of results for at-a-glance performance assessment.  Access to instantly updated peer group data and automatically generated statistics also helps to speed up data review. To view more of our quality control products click here.

 

 

Linearity Verifier Sets | Key Features and Benefits

Click each icon for full features and benefits

 

 

 

 

null
null

Data Reduction Software

Complimentary data reduction software is provided delivering an immediate indication of performance.
null
null

Liquid Samples

All samples are provided in a user-friendly, liquid format significantly reducing preparation time and the risk of pipetting errors.
null
null

Consolidation

Reduce costs, storage space and the number of individual products required to cover your test menu with our comprehensive, multi-analyte Calibration Verifiers.
null
null

Clinically Relevant Levels

Designed to challenge the whole analytical measuring range, helping ensure accurate/reliable performance. 5 levels removes the need for manual dilution and allows for more comprehensive assessment than the minimum requirement of 3 levels set by CLIA.
null
null

Instrument Dedicated

Help to ensure specific instrument requirements are met with the availability of dedicated solution for Roche Cobas systems.
null
null

Stability

An extended open vial stability keeps waste to a minimum and ensures availability of product for troubleshooting.
Solutions for Roche Cobas Analysers

 

Solutions for Beckman Analysers

 

Want to know more?

Make an Enquiry about Linearity Verifier Sets or Download our brochure:

   Related Products:

Acusera - Quality Control

Contact Us

Resource Hub


Randox QC Resource Hub

  • Brochures
  • Support Tools
  • Educational Items
  • Posters
  • Industry Articles
  • Webinars
  • Videos
  • Blog
  • Testimonials

Acusera Third Party Controls

Acusera 24•7

Infectious Disease Controls (Serology)

Importance of Third Party Controls

Acusera Point of Care Controls

Acusera Linearity Sets

IQC - Liquid 30 Day Controls

RIQAS External Quality Assessment

RIQAS Point of Care (RIQAS POC)

Qnostics - Molecular Infectious Disease Controls

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

RIQAS-Troubleshooting Checklist - Download

RIQAS Troubleshooting Checklist

How to Establish QC Reference Ranges

The Cost of Poor Quality in the Clinical Laboratory

The Role of Six Sigma in a Modern QC Strategy

How Often Is Right For QC - Download

How Often Is Right For QC

How To Measure Uncertainty

ISO 15189:2012 Accreditation Guide

QC Multi-Rules

The Role of EQA in QC

Troubleshooting QC Errors

What Format Is Best For Your Laboratory - Download

What Format Is Best For Your Laboratory

Which QC is The Right QC - Downloads

Which QC is The Right QC

Basic QC Statistics

Commutability

Designing An Appropriate QC Design Procedure

ISO 15189 Requirements for Measurement Uncertainty

Quality Control for POCT - Download

Quality Control for POCT

Importance of Third Party Controls in Molecular Infectious Disease Testing

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

RIQAS Frequency - Lipase

RIQAS Past Panels Flyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

RIQAS Report Interpretation

Importance of Third Party Controls in Molecular Diagnostics

Fully syndromic approach to molecular testing

SARS-CoV-2 Proficiency Testing

RIQAS Reporting

The Role of EQA in QC Management

Importance of EQA

Utilisation of QC Software for Identification of Performance Issues

Why is the third party QC important for COVID-19 detection in Molecular testing

Importance of Third Party Controls in Molecular Diagnostics

Performance & Statistics - How EQA Can Help You Excel

Acusera 24•7 Webinar: Utilisation of QC software and metrics to help identify performance issues

The Need for Robust Molecular Quality Assurance in the Wake of the Pandemic

Acusera Third Party Controls

True Third Party Controls

Randox Acusera Quality Controls

Consolidation

RIQAS – External Quality Assessment Scheme

Acusera 24.7 Live Online

Guide to Running Quality Control

Medical Lab Professionals Week 2016

QC Serology Video

Acusera 247 Video

Acusera 24•7 Interlaboratory Data Management

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Customer Testimonial | Dr Bianca Thakkar

Customer Testimonial | Dr. Anil Shah

Customer Testimonial | Dr Pragati Desai

Customer Testimonial | Dr Pramod Ingale

Customer Testimonial | Dr Rajeev Mehta

Customer Testimonial | Dr Simple Bhuptani

Customer Testimonial | Dr SM Patel

Customer Testimonial | Dr Trupti Patel

Customer Testimonial | Dr A Vahed Mulla


Tackling Worldwide Drugs of Abuse

Throughout November, we’ve been highlighting how the Randox clinical teams – Randox Rx series, Randox Reagents and Randox QC – are aiding the fight against drugs of abuse.

Drugs of Abuse are a growing problem worldwide and represent a significant burden to healthcare systems as well as creating problems in an individual’s lifestyle. It has been estimated by the WHO (World Health Organisation) that 31 million people globally suffer from drug use disorders and 3.3 million deaths each year are linked to the abuse of both drugs and alcohol.

The abuse of drugs is one of the most pressing issues in the United States of America. Drug abuse not only affects the individual, but also can have far-reaching consequences that affect family, employment, personal health, health care systems, local communities, and society as a whole.

  • Misuse of illicit drugs affects society through secondary costs incurred such as crime, reduced productivity at work, and health care expenses.
  • Substance abuse costs the US health care system about $11 billion, with overall costs reaching $193 billion.
  • Substance abuse and addiction also affects other areas of life and can cause broken families, destroyed careers, death due to negligence or accident, domestic violence, physical abuse and child abuse.
  • Drug abuse and addiction changes the chemistry of your brain. The longer you use your drug of choice, the more damage is caused and it becomes more difficult to return to ‘normal’ during drug rehabilitation.
  • In 2013, 22.7 million Americans needed treatment for a substance use disorder – almost 9% of the population over the age of 12. Only about 2.5 million received treatment as a specialist facility with 20% of admissions for opiate addication treatment and 17% for the treatment of marijuana abuse.

To find out more about how Randox is helping in the fight against Drugs of Abuse, please visit https://www.randox.com/drugs-of-abuse/ or for more information about Randox RX, Randox Reagents or Randox QC, please email marketing@randox.com.

 

 


Product Spotlight: HbA1c Quality Controls

Randox Quality Contol Logo

Product Spotlight

HbA1c Quality Controls

Diabetes

Diabetes is a life-long condition which occurs when the glucose level in the blood is too high because it can’t enter the body’s cells to be used as fuel. There are two types of diabetes: type 1 and type 2. They are distinct conditions and must be treated and managed differently.

Type 1 Diabetes

Type one diabetes is an autoimmune condition in which the body attacks insulin-producing cells, this causes a lack of insulin, leading to an increased blood glucose level. Around 10% of people with diabetes has type 1.

Type 2 Diabetes

A mixture of genetic and environmental factors causes type 2 diabetes. The body doesn’t make enough insulin or the insulin it does create does not work correctly, leading to a glucose build up in the blood. It’s thought that up to 58% of type 2 diabetes can be prevented or delayed through healthy lifestyle choices.

HbA1c

HbA1c is the average blood glucose level for the past two to tthree months. A high HbA1c means there is too much sugar in the bloodstream. This means the patient is more likely to develop complications associated with diabetes, like problems with feet and eyes [1].

HbA1c in Diagnostics

In 2011, the WHO accepted the use of glycated haemoglobin (HbA1c) testing in the diagnosis of diabetes, Diabetes UK also supports this decsion [2].

HbA1c can be used as a diagnostic test for diabetes providing that stringent quality assurance tests are in place and assays are standardised to criteria aligned to the international reference values, and there are no conditions present which preclude its accurate measurement.”
World Health Organisation (2011)

Clinically Significant Levels

A HbA1c level of 6.5% is recomended as the cut off for diabetes diagnosis [3], this can be seen in Fig. 1.

HbA1c Levels

Fig. 1. Clinically relevant levels for Diabetes diagnosis.

Acusera HbA1c Controls

Acusera HbA1c Quality Control

The Randox Acusera HbA1c control is designed for use in the quality control of both HbA1c and Total Haemoglobin assays. Assayed instrument and method specific target values and ranges are provided for all major systems and methods including HPLC. A reconstituted stability of 4 weeks keeps waste to a minimum and helps to reduce costs.

View HbA1c Control

Acusera Liquid HbA1c Quality Control

Conveniently supplied liquid ready-to-use the Liquid HbA1c control is ideally suited to both clinical laboratories and POCT helping to significantly reduce preparation time. With a stability of 30 days waste and costs are also kept to a minimum.

View Liquid HbA1c Control
Continue Reading

Flu Season

Molecular Respiratory Testing

Contact Us

Product Spotlight Home

Visit the Product spotlight Home to see past product spotlights

  • References

    [1] “What is HbA1c?”, Diabetes UK, 2018. [Online] Availabel: https://www.diabetes.org.uk/guide-to-diabetes/managing-you-diabetes/hba1c.

    [2] Diabetes UK, “Diagnostics criteria for deabetes”, Diabetes UK, 2018. [Online]. Available: https://www.diabetes.org.uk/professionals/position-statements-reports/diagnosis-ongoing-management-monitoring/new_diagnostic_criteria_for_diabetes.

    [3] WHO, “Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus”, World Health Organisation, 2011.


November focus: Drugs of Abuse

Throughout November, the Randox clinical teams – Randox Reagents, Randox Rx series and Randox QC – will be highlighting how the Randox product range can be utilised to allow for the most accurate analysis of Drugs of Abuse, with a particular focus placed with the Evidence MultiSTAT. The Evidence MultiSTAT is a fast, fully automated and versatile immunoanalyser that enables on-site detection of up to 21 Drugs of Abuse from a single sample of oral fluid, urine or blood.

Drugs of Abuse are a growing problem worldwide and represent a significant burden to healthcare systems as well as creating problems in an individual’s lifestyle.  It has been estimated by the WHO (World Health Organisation) that 31 million people globally suffer from drug use disorders and 3.3 million deaths each year are linked to the abuse of both drugs and alcohol.

Randox have reacted to this growing concern and are now a world leader in the Drugs of Abuse testing field.  Our product range currently comprises classical, prescription and synthetic drugs.

The Evidence MultiSTAT offers a simple drug screening solution to those who have little or no knowledge of laboratory procedures. As an extremely versatile desktop analyser, it is ideally suited to a variety of settings including both the clinical laboratory and the emergency room.

Randox Reagents – Drugs of Abuse Assays

In order to assist in dealing with the ongoing burden of substance abuse, Randox Reagents offer a comprehensive range of ten assays to test for some of the top most commonly-abused substances including alcohol, methamphetamines, cocaine, methadone, cannabis, benzodiazepines, barbiturates, EDDP and ecstasy and opiates.  The Randox Drugs of Abuse assays are liquid, ready-to-use for increased efficiency and applications are available for over 30 different analysers.

RX Series – Toxicology testing

Renowned for quality and reliability, the RX series range of clinical chemistry analysers boasts a world-leading test menu comprising of both therapeutic drugs and Drugs of Abuse.  Our toxicology range comprises amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, ecstasy, EDDP, ethanol, methadone and opiates. The RX series range of clinical chemistry analysers ensures a high degree of accuracy with a wide range of testing throughputs to suit all laboratories, big or small.

RIQAS Urine Toxicology Programme

Designed to monitor the performance of 20 Drugs of Abuse tests in urine, our RIQAS urine toxicology EQA program is suitable for both qualitative and quantitative methods of analysis.  As the largest EQA scheme in the world, access to large peer groups is guaranteed.  Additional benefits include; monthly analysis, user-friendly reports allowing at-a-glance performance assessment, ability to register up to five instruments per programme and cost savings via our unrivalled consolidation.

For more information about Randox RX, Randox Reagents or Randox QC, please email marketing@randox.com.

 

 


sTfR Quality Control

Therapeutic Drug Quality Control

Providing a true third party solution for the measurement of Soluble Transferrin Receptor (sTfR), the Acusera sTfR Control  will deliver an unbiased, independent assessment of analytical performance.

Designed for used with sTfR assays, this handy single analyte control saves money on wasted material.

Features & Benefits

  • Lyophilised control
  • Human based material
  • Assayed target values available
  • Stable to expiry date at 2°C to 8°C
  • Reconstituted stability of 30 days at 2°C to 8°C
DescriptionSizeAnalytesCat No 
sTfR Control (Bi-level)3 x 2 x 1 ml1TF10162
sTfR Calibrator6 x 1 ml1TF10161

Analytes

  • Soluble Transferrin Receptor (sTfR)

Related Products


Metabolic Syndrome Array II Quality Control

Therapeutic Drug Quality Control

A multi-analyte quality control with target values and ranges provided for 3 parameters associated with metabolic syndrome.

Features & Benefits

  • Lyophilised for enhanced stability
  • 100% human material
  • Stable to expiry date at 2oC – 8oC
  • Reconstituted stability of 72 hours at 2oC – 8oC and 7 days at -20°C
  • Assayed values available for Randox Biochip systems
DescriptionSizeAnalytesCat No 
Metabolic Syndrome Array II Control3 x 3 x 1ml3EV3761
Metabolic Syndrome Array II Calibrator9 x 1 ml3EV3760

Analytes

  • Adiponectin
  • CRP
  • Cystatin C

Randox QC Resource Hub

Randox Quality Contol Logo

Quality Control | Resource Hub

  • Brochures
  • Educational Items
  • Posters
  • Industry Articles
  • Podcasts
  • Videos
  • Blog
LT027 - Acusera Third Party Controls

Acusera Third Party Controls

LT324 - Importance of Third Party Controls - Download

Importance of Third Party Controls

LT244 - Acusera 24.7 - Interlaboratory Data Management - Download

Acusera 24•7

LT033 - RIQAS - Randox International Quality Assessment Scheme - Download

RIQAS External Quality Assessment

RIQAS-Troubleshooting Checklist - Download

RIQAS Troubleshooting Checklist

LT737 - Qnostics Molecular Controls for Infectious Diseases

Qnostics - Molecular Infectious Disease Controls

LT739 - QCMD EQA for Molecular Infectious Disease Testing

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

How to Establish QC Reference Ranges - Downloads

How to Establish QC Reference Ranges

The Cost of Poor Quality in the Clinical Laboratory - Download

The Cost of Poor Quality in the Clinical Laboratory

The Role of Six Sigma in a Modern-Quality Management Strategy - Download

The Role of Six Sigma in a Modern QC Strategy

How Often Is Right For QC - Download

How Often Is Right For QC

How To Measure Uncertainty - Download

How To Measure Uncertainty

Gaining ISO 15189 Accreditation - Download

Gaining ISO 15189 Accreditation

QC Multi-Rules - Download

QC Multi-Rules

The Role of EQA in QC - Download

The Role of EQA in QC

Troubleshooting QC Errors - Download

Troubleshooting QC Errors

What Format Is Best For Your Laboratory - Download

What Format Is Best For Your Laboratory

Which QC is The Right QC - Downloads

Which QC is The Right QC

Basic QC Statistics - Download

Basic QC Statistics

Commutability Guide - Download

Commutability Guide

Designing An Appropriate QC Design Procedure For Your Lab - Download

Designing An Appropriate QC Design Procedure

Meeting ISO-15189 Requirements - Download

ISO 15189 Requirements for Measurement Uncertainty

Quality Control for POCT - Download

Quality Control for POCT

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

RIQAS User Forum

RIQAS User Forum

Lab Week 2017 – The Unsung Heroes of Healthcare - Podcast

Acusera 24.7 New Features

Lab Week 2017 – The Unsung Heroes of Healthcare - Podcast

Lab Week 2017 – The Unsung Heroes of Healthcare

Acusera Third Party Controls

True Third Party Controls

Randox Acusera Quality Controls

Consolidation

RIQAS – External Quality Assessment Scheme

Acusera 24.7

Guide to Running Quality Control

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Medical Lab Professionals Week 2016


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents